Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation

Rama Krishna Kancha, Nikolas Von Bubnoff, Cornelius Miething, Christian Peschel, Katharina S. Götze, Justus Duyster*

*Korrespondierende/r Autor/-in für diese Arbeit
18 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medizin & Biologie